Summary
Rocket Lab Corporation has announced a significant acquisition, entering into a Stock Purchase Agreement to acquire all outstanding ordinary shares of Mynaric AG, a German-based company. This strategic move is valued at an aggregate of $75 million, with the consideration payable in either cash or Rocket Lab's common stock at the company's discretion. The deal also includes potential post-closing earnout payments of up to $75 million, contingent on Mynaric's revenue performance in 2025, 2026, and 2027, also payable in cash or stock. The acquisition, if completed, represents a substantial expansion for Rocket Lab, integrating Mynaric's business into its operations. The consideration for the transaction, including any stock issued, will be made under exemptions from registration requirements, specifically Section 4(a)(2) of the Securities Act of 1933. Rocket Lab has committed to filing a resale registration statement for any shares issued in the transaction within 30 days post-closing, providing liquidity assurances for those receiving stock. The transaction is subject to customary closing conditions and regulatory approval from the German Ministry of Foreign Affairs.
Key Highlights
- 1Rocket Lab enters agreement to acquire Mynaric AG for $75 million, with payment in cash or Rocket Lab common stock.
- 2Potential for up to $75 million in post-closing earnout payments based on Mynaric's revenue targets for 2025-2027.
- 3Earnout payments can also be settled in cash or Rocket Lab common stock.
- 4Acquisition consideration issued under an exemption from SEC registration requirements (Section 4(a)(2)).
- 5Rocket Lab to file a resale registration statement for issued stock within 30 days post-closing.
- 6Transaction is subject to regulatory approval from the German Ministry of Foreign Affairs.
- 7The acquisition is structured with customary representations, warranties, and closing conditions.